
Corporate
Arrowhead's Gene Silencing Drugs Double Tirzepatide's Weight Loss, Sending Shares Surging
Jan 6
You're signed outSign in or to get full access.
Browse quarterly earnings call transcripts for ARROWHEAD PHARMACEUTICALS.
Feb 5, 2026
Nov 25, 2025
Aug 7, 2025
May 12, 2025
Feb 10, 2025
Aug 8, 2024
May 9, 2024
Aug 5, 2021
May 4, 2021
Feb 4, 2021
Nov 23, 2020
Aug 5, 2020
May 7, 2020